Literature DB >> 16043002

Family evaluation of hospice care: results from voluntary submission of data via website.

Stephen R Connor1, Joan Teno, Carol Spence, Neal Smith.   

Abstract

The Family Evaluation of Hospice Care (FEHC) survey is a 61-item questionnaire that surveys family members about care provided to the decedent by the hospice. Hospices submit their data to the National Hospice and Palliative Care Organization (NHPCO), where results are tabulated. For the first two quarters of 2004, a total of 29,292 surveys were tabulated. On average, respondents rated their overall satisfaction with care as 47.1 on a 50-point composite scale of five measures of satisfaction. Opportunities for improvement were identified for attending to family needs for support (18.2% of those surveyed reported at least one unmet need), attending to family needs for communication (10-29%), and coordination of care (22.1%). Surrogate reporting of unmet needs for pain, dyspnea, or emotional support ranged from 5.3% to 9.8%. The FEHC is a useful tool for measuring hospice performance and identifies a number of opportunities for improvement.

Entities:  

Mesh:

Year:  2005        PMID: 16043002     DOI: 10.1016/j.jpainsymman.2005.04.001

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  22 in total

1.  Hispanic language version of the family evaluation of hospice care.

Authors:  Jason Portenoy; Joan M Teno
Journal:  J Pain Symptom Manage       Date:  2007-10-24       Impact factor: 3.612

Review 2.  Measuring Experience With End-of-Life Care: A Systematic Literature Review.

Authors:  Jessica Penn Lendon; Sangeeta C Ahluwalia; Anne M Walling; Karl A Lorenz; Oluwatobi A Oluwatola; Rebecca Anhang Price; Denise Quigley; Joan M Teno
Journal:  J Pain Symptom Manage       Date:  2014-12-24       Impact factor: 3.612

3.  Use of electronic documentation for quality improvement in hospice.

Authors:  John G Cagle; Franziska S Rokoske; Danielle Durham; Anna P Schenck; Carol Spence; Laura C Hanson
Journal:  Am J Med Qual       Date:  2012-01-20       Impact factor: 1.852

4.  Quality of Hospice Care at Home Versus in an Assisted Living Facility or Nursing Home.

Authors:  Kathleen T Unroe; Timothy E Stump; Shannon Effler; Wanzhu Tu; Christopher M Callahan
Journal:  J Am Geriatr Soc       Date:  2018-02-10       Impact factor: 5.562

5.  Unintended Harm? Race Differences in the Relationship Between Advance Care Planning and Psychological Distress at the End of Life.

Authors:  Elizabeth A Luth; Holly G Prigerson
Journal:  J Pain Symptom Manage       Date:  2018-08-08       Impact factor: 3.612

6.  Effect of the Goals of Care Intervention for Advanced Dementia: A Randomized Clinical Trial.

Authors:  Laura C Hanson; Sheryl Zimmerman; Mi-Kyung Song; Feng-Chang Lin; Cherie Rosemond; Timothy S Carey; Susan L Mitchell
Journal:  JAMA Intern Med       Date:  2017-01-01       Impact factor: 21.873

7.  Organization of nursing and quality of care for veterans at the end of life.

Authors:  Ann Kutney-Lee; Caitlin W Brennan; Mark Meterko; Mary Ersek
Journal:  J Pain Symptom Manage       Date:  2014-08-10       Impact factor: 3.612

8.  In-advance end-of-life discussions and the quality of inpatient end-of-life care: a pilot study in bereaved primary caregivers of advanced cancer patients.

Authors:  Masanori Mori; Donna Ellison; Takamaru Ashikaga; Ursula McVeigh; Allan Ramsay; Steven Ades
Journal:  Support Care Cancer       Date:  2012-08-30       Impact factor: 3.603

9.  Current state of pain care for hospitalized patients at end of life.

Authors:  Yingwei Yao; Gail Keenan; Fadi Al-Masalha; Karen Dunn Lopez; Ashfaq Khokar; Andrew Johnson; Rashid Ansari; Diana J Wilkie
Journal:  Am J Hosp Palliat Care       Date:  2012-05-02       Impact factor: 2.500

10.  Measuring Patient-Centeredness of Care for Seriously Ill Individuals: Challenges and Opportunities for Accountability Initiatives.

Authors:  Rebecca Anhang Price; Marc N Elliott
Journal:  J Palliat Med       Date:  2017-11-01       Impact factor: 2.947

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.